Compounded weight-management care

Weight loss, personalized to your body and your goals.

Compounded Semaglutide/B12

Compounded semaglutide works through GLP-1 receptor activity to support appetite regulation and weight management. Graceland Wellness prescribes it, paired with B12, only for eligible patients when a patient-specific compounded treatment is clinically appropriate.

  • Semaglutide supports appetite regulation and weight management through GLP-1 receptor activity
  • Weekly subcutaneous injection with individualized prescribing and titration
  • Cyanocobalamin (vitamin B12) included as part of the compounded formulation
  • Private telehealth evaluation, ongoing follow-up, and clear injection guidance
1 / 4
Provider guided
Support for steady progress

Support for steady progress

Personalized dosing, a weekly routine, B12 nutritional support, and provider-guided care.

The image shown is for illustrative purposes only and does not represent the actual appearance of your specific compounded medication.

Type
GLP-1 injection
Frequency
Once weekly
Formula
Semaglutide + B12
Status
Not FDA-approved
Access
Prescription only
The formulation

A clear visual overview of the formulation

Your clinician and dispensing pharmacy determine the patient-specific concentration, dose, and administration instructions.

Compounded Semaglutide B12 overview
Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Treatment requires provider evaluation and a patient-specific prescription. Your prescription label and clinician instructions control your exact dose and administration.
What is included

Two components. One compounded injection

Each ingredient has a distinct role. The inclusion of B12 does not establish greater weight-loss effectiveness or fewer side effects.

Two components one compounded injection
Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Treatment requires provider evaluation and a patient-specific prescription. Your prescription label and clinician instructions control your exact dose and administration.

Patient-specific prescribing comes first

This formulation is prescribed only after a clinician reviews your health history, goals, medications, contraindications, and available alternatives.

  • Semaglutide activates GLP-1 receptors involved in appetite regulation and fullness.

  • Cyanocobalamin is vitamin B12 included as part of the compounded formulation when clinically appropriate.

  • Individualized instructions come from your prescription label and clinician—not a universal online dose chart.

The specific compounded formulation has not been independently studied in clinical trials. No particular outcome is guaranteed.

Dosing precision

Measure the prescribed dose exactly

Concentration can vary between compounded products. FDA has reported dosing errors caused by confusion between milligrams, milliliters, and syringe “units.”

Before every injection

  • Confirm the medication name, concentration, and prescribed dose.
  • Use the syringe and markings specified by your pharmacy.
  • Ask your Care Team to clarify any mismatch or uncertainty before injecting.
  • Never convert between mg, mL, and units or adjust your own dose.
Woman administering a subcutaneous injection
Injection guidance

A clear weekly routine

Your prescription label and clinician instructions always control your exact dose and administration.

  1. Confirm medication and dose

    Read the label and verify the prescribed amount before drawing medication into the syringe.

  2. Measure exactly

    Use only the supplied or recommended syringe. Do not estimate, convert, or change the prescribed dose.

  3. Inject subcutaneously

    Use the technique demonstrated by your Care Team and rotate among approved injection sites each week.

Appropriate use

Prescribed for your specific clinical needs

Compounded treatment is considered only after a licensed provider reviews whether it is appropriate for you and discusses available FDA-approved alternatives.

  • Clinical review. Your provider evaluates your history, current medications, and contraindications.

  • Documented consent. You receive a clear explanation of the compounded product's regulatory status, risks, and alternatives.

  • Ongoing oversight. Follow-up supports tolerability, safe titration, and questions about administration.

Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or efficacy.

Common side effects

Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, indigestion, and fatigue may occur, especially during titration.

Serious risks

Risks include pancreatitis, gallbladder disease, kidney injury from dehydration, serious allergic reactions, severe gastrointestinal problems, low blood sugar with certain diabetes medicines, and complications related to diabetic retinopathy.

Tell every treating clinician

Semaglutide delays stomach emptying and may affect procedures involving anesthesia or deep sedation. Share your medication list before any procedure.

Pregnancy

Weight-loss treatment should not be used during pregnancy. Tell your provider if you are pregnant, planning pregnancy, or breastfeeding.

Habits that last

Build habits that support the progress you want

Medication can support appetite regulation, while practical nutrition, movement, sleep, and stress routines help make your plan sustainable. Your Care Team helps you focus on realistic changes—not perfection.

Couple preparing healthy food
Woman holding compounded Semaglutide B12 vial
Ongoing care

Small steps. Consistent follow-up.

Your provider reviews how treatment is going before deciding whether to continue, hold, or change your dose.

  • Share side effects early. Your Care Team can help you decide what needs attention.
  • Do not rush titration. Dose changes are based on tolerability and clinical response.
  • Ask before changing anything. Never adjust your own dose, syringe volume, or injection schedule.
Questions, answered

Compounded Semaglutide/B12, explained

Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Treatment requires provider evaluation and a patient-specific prescription. Your prescription label and clinician instructions control your exact dose and administration.

Personalized weight-management care

Find out whether this option is appropriate for you

Complete a private assessment for review by a licensed provider. A prescription is never guaranteed, and your clinician will discuss appropriate options based on your health history.

Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Treatment requires provider evaluation and a patient-specific prescription. Your prescription label and clinician instructions control your exact dose and administration.